Genscript Biotech
1548.HK
#3757
Rank
$2.47 B
Marketcap
$1.16
Share price
-1.09%
Change (1 day)
-53.86%
Change (1 year)

P/E ratio for Genscript Biotech (1548.HK)

P/E ratio at the end of 2021: -23.1

According to Genscript Biotech 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -6.65071. At the end of 2021 the company had a P/E ratio of -23.1.

P/E ratio history for Genscript Biotech from 2015 to 2021

PE ratio at the end of each year

Year P/E ratio Change
2021-23.173.76%
2020-13.3-69.78%
2019-44.0-140.01%
2018110-34.63%
2017168457.76%
201630.2162.45%
201511.5

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.